Gary Fong, PharmD, BCPS E-mail: [email protected] Training Baylor St Luke’s Medical Center/University of Houston College of Pharmacy 2015 – 2017 Infectious Diseases Pharmacotherapy Fellowship University of California, San Francisco Medical Center 2014 – 2015 PGY-1 Pharmacy Practice Residency University of California, San Francisco 2010 – 2014 Doctor of Pharmacy University of California, Los Angeles 2006 – 2010 Bachelor of Science: Microbiology, Immunology, and Molecular Genetics Professional Experience Assistant Professor, Infectious Diseases 8/17 – Present Department of Pharmacy Practice, Chapman University School of Pharmacy Clinical Pharmacist I 7/15 – 6/27 Baylor St. Luke’s Medical Center, Houston, TX Staff Pharmacist 8/14 – 6/15 UCSF Medical Center, San Francisco, CA Intern Pharmacist 5/12 – 3/13 Novato Community Hospital, Novato, CA Teaching Experience Pharmacy 5581: Advanced Therapeutics 1. Teaching Assistant/Guest Lecturer 10/15 – 12/15 University of Houston College of Pharmacy, Houston, TX 10/16 – 12/16 Physical Therapy 211: Pharmacology. Assistant Instructor/Guest Lecturer 4/15 UCSF School of Pharmacy, San Francisco, CA Clinical Pharmacy 120: Therapeutics. Teaching Assistant/Guest Lecturer 1/15 – 3/15 UCSF School of Pharmacy, San Francisco, CA Biopharmaceutics 122: Clinical Pharmacokinetics. Teaching Assistant 1/13 – 3/13 UCSF School of Pharmacy, San Francisco, CA Gary Fong, PharmD, BCPS Page 1 | 4 Peer Reviewed Publications Fong G, Skoglund EW, Phe K, et al. Significant publications on infectious diseases pharmacotherapy in 2016. J Pharm Pract. 2017. Submitted for review. Vitt JR, Do LV, Shah NR, Fong G, et al. A before-after study of an electronic order set for reversal of vitamin K antagonist-associated intracerebral hemorrhage. Neurohospitalist. 2017. Accepted for publication. Corelli RL, Muchnik MA, Beechinor RJ, Fong G, et al. Perceptions and cost-analysis of a multiple mini- interview in a pharmacy school admissions process. Am J Pharm Educ. 2015. 79(9):135. Peer Reviewed Presentations Poster Presentation: Fong G, Lasco TM, Beyda ND. Ventricular assist device associated candidemia: treatment outcomes and resistance patterns. 2017. ASM Microbe, New Orleans, LA. Poster Presentation: Hu C, Fong G, Beyda ND. FKS-Mediated echinocandin resistance does not impact the virulence of Candida glabrata. 2017. ASM Microbe, New Orleans, LA. Platform Presentation: Fong G, Lasco TM, Beyda ND. Risk factors for treatment failure and antifungal resistance patterns in patients with ventricular assist device (VAD) associated candidemia. 2017. ID Pharmacy Fellowship Forum, Detroit, MI. Poster Presentation: Ngo K, Fong G, Russo HR et al. Treatment patterns and outcomes in adult patients with Candida parapsilosis candidemia at a large academic medical center: a retrospective cohort study. 2016. ASHP Midyear Meeting, Los Vegas, NV. Platform Presentation: Fong G, Phe K, Lasco TM et al. Ceftolozane-tazobactam for the treatment of multi- drug resistant Pseudomonas aeruginosa. 2016. Alcáldé Seminar, Frisco, TX. Poster Presentation: Fong G, Phe K, Russo HR. Nephrotoxicity rates in patients receiving vancomycin and piperacillin-tazobactam compared to vancomycin and cefepime. 2016. TSHP Annual Seminar, Frisco, TX. Platform Presentation: Fong G, Do LV, Nguyen NY et al. Impact of an order set on PCC administration time for urgent bleeding. 2015. Western States Seminar, San Diego, CA. Poster Presentation: Fong G, Do LV, Nguyen NY et al. The impact of a standardized electronic order set on improving time to administration of prothrombin complex concentrate for urgent anticoagulation reversal. 2014. UHC Annual Conference, Anaheim, CA. Poster Presentation: Fong G, Beechinor RJ, Creason MB et al. Perceptions and cost-analysis of a multiple mini-interview in a pharmacy school admissions process. 2013. ASHP Midyear Meeting, Orlando, FL. Gary Fong, PharmD, BCPS Page 2 | 4 Editorial Experience Independent Review 3/17 – Present Journal of Pharmacy Practice – 1 manuscript reviewed Postdoctoral Review (under Hannah R. Russo and Nicholas D. Beyda) 10/15 – Present Antimicrobial Agents and Chemotherapy – 1 manuscript reviewed Epidemiology and Infection – 1 manuscript reviewed BioMed Central Infectious Diseases – 1 manuscript reviewed Invited Presentations Seminar: Practical Use of Aminoglycosides 2/17 Case presentation: Vibrio vulnificus 7/16 Infectious diseases lecture (MD Fellows): Antibiotic dosing in critically ill patients 4/16 Case presentation: Vancomycin PK/PD 3/16 Seminar: Antifungal Resistance: Candida glabrata 11/15 CME (Lufkin Memorial Hospital): Antibiotic Stewardship 10/15 Case presentation: Mycobacterium abscessus 10/15 Infectious diseases lecture (MD Residents): Gram-Negative Resistance 9/15 Seminar: Pediatric Vancomycin PK/PD 6/15 Seminar: An Update on Beta-Lactams in Staphylococcal Bacteremia 12/14 Infectious diseases lecture (MD Fellows): Vancomycin PK/PD in Pediatrics 11/13 Leadership SIDP Membership Committee 11/16 – Present UHCOP Admissions Interviewer 10/16 – 2/17 SNPhA – SCCP Mentorship program 9/16 – 6/17 CASE Advisory Board Member (Baylor St. Luke’s Medical Center) 7/16 – 6/17 Antibiotic Subcommittee Member (UCSF Medical Center) 7/14 – 6/15 Chief Resident (UCSF 2014 – 2015 Residency Class) 7/14 – 10/14 UCSF Admissions Committee Interviewer 1/13 – 3/13 Gary Fong, PharmD, BCPS Page 3 | 4 Awards and Recognition MAD-ID Trainee Travel Grant 2017 ASM Infectious Diseases Fellows Program Travel Award 2017 Apple Teaching Award 6/13, 4/15 The Long Award for Excellence in Teaching 2012 – 2013 Licensures and Certifications Board Certified Pharmacotherapy Specialist California Registered Pharmacist #70740 Texas Registered Pharmacist #56837 UCSF Teaching Certificate Professional Organizations American Society for Microbiology (ASM) Society of Infectious Disease Pharmacists (SIDP) Making a Difference in Infectious Diseases (MAD-ID) Houston Infectious Diseases Network (HIDN) American Society of Health-Systems Pharmacists (ASHP) American College of Clinical Pharmacy (ACCP) Gary Fong, PharmD, BCPS Page 4 | 4 .